Profound Medical Corp. , together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland.
Profound Medical stock last closed at $8.28, up 1.6% from the previous day, and has decreased 9.41% in one year. It has underperformed other stocks in the Medical Devices industry by 0.04 percentage points. Profound Medical stock is currently +16.46% from its 52-week low of $7.11, and -46.55% from its 52-week high of $15.49.
At the moment, there are 21.37M PROF shares outstanding. The market capitalization of PROF is $176.95M. In the last 24 hours, 34,051 PROF shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy PROF stock.
Based on our analysis, eToro is the best brokerage. Here's why:
Get $10 towards your purchase of stock by signing up for an account with eToro now.
Open eToro AccountNow that you've chosen your brokerage, it's time to fill out some personal info so you can buy PROF today.
Now that you have finished signing up on one of the most highly reviewed stock apps, you need to deposit funds:
Check out the video below to see the process of depositing funds into your new investment account.
After you have figured out the best place to buy Profound Medical stock, it's absolutely critical to research their stock before you buy, so you truly comprehend the risk as well as the opportunity.
WallStreetZen was built to help average investors perform better fundamental analysis.
You can view all of the due diligence checks on PROF's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge PROF's fair value.
Using relative valuations methods:
You can access more valuation analysis on PROF's stock here.
Out of 2 sell side analysts who monitor PROF, the consensus analyst rating on Profound Medical is a Buy
Please note that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are saying on the Profound Medical stock forecast page.
Last year, PROF revenue was $5.29M. In the past five year, PROF's revenue has increased by 22.94% per year. This was faster than the Medical Devices industry average of 13.08%.
Learn more about PROF's earnings and revenue performance here.
Over the past 12 months, insiders at PROF have not bought or sold any shares.
Dig into more about who owns PROF shares here.
No, Profound Medical doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
There are two main order types:
Press the Open Trade button and your broker will place the order.
If you need more help with investing in stocks on eToro, watch the helpful video below:
Now that you own some PROF shares, you'll want to keep up with your investment.
Make a watchlist to keep track of your PROF stock.
To reiterate, here are the 6 steps for buying Profound Medical stock:
If you require a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to watch your investment in Profound Medical, get started below.